February 14, 2018 / 9:34 PM / 10 months ago

BRIEF-Ohr Pharmaceutical Q1 Loss Per Share $0.07

Feb 14 (Reuters) - Ohr Pharmaceutical Inc:

* OHR PHARMACEUTICAL REPORTS FISCAL FIRST QUARTER 2018 FINANCIAL RESULTS

* Q1 LOSS PER SHARE $0.07

* OHR PHARMACEUTICAL - ‍BOARD HAS ENGAGED ROTH CAPITAL MARKETS, TO ADVISE BOARD AND MANAGEMENT, TO ASSIST IN PURSUING RANGE OF STRATEGIC ALTERNATIVES​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below